VistaGen Therapeutics Inc. (NASDAQ: VTGN)
$3.89
+0.0500 ( +1.30% ) 94.2K
Vistagen Therapeutics Inc is a biotechnology firm. The company is neuroscience-focused biopharmaceutical company dedicated to pursuing a pioneering approach to the development and commercialization of groundbreaking therapies for psychiatric and neurological disorders based on deep understanding of nose-to-brain neurocircuitry.
Market Data
Open
$3.89
Previous close
$3.84
Volume
94.2K
Market cap
$105.67M
Day range
$3.72 - $3.96
52 week range
$1.63 - $24.71
SEC Fillings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 8-k | 8K-related | 15 | Aug 07, 2023 |
| def | Proxies and info statements | 16 | Jul 28, 2023 |
| 8-k | 8K-related | 15 | Jul 18, 2023 |
| 8-k | 8K-related | 15 | Jul 13, 2023 |
| 8-k | 8K-related | 13 | Jul 07, 2023 |
| 4 | Insider transactions | 1 | Jul 05, 2023 |
| 4 | Insider transactions | 1 | Jul 05, 2023 |
| 4 | Insider transactions | 1 | Jul 05, 2023 |